Conduit Pharmaceuticals receives Nasdaq extension, plans transfer to Capital Market

CDT Equity Inc.

Nasdaq Hearing Panel granted extension to March 31, 2025 to regain MVPHS and MVLS compliance.
Company must file application to transfer to Nasdaq Capital Market by March 12, 2025.
Bid Price compliance regained as of February 26, 2025; extension conditional on meeting all listing rules.
Company believes it can satisfy equity standard of >$2.5M stockholder's equity before deadline.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.